Chinese pharmaceutical firm Sinovac Biotech stood by the safety of its Covid-19 vaccine after Brazilian regulators halted trials in the South American country citing an “adverse incident” involving a volunteer recipient, according to AFP.
“We are confident in the safety of the vaccine,” Sinovac said in a statement, adding that the adverse incident was “unrelated to the vaccine”.
